Fig. 1From: A comparison of radiographic and clinical outcomes of anterior lumbar interbody fusion performed with either a cellular bone allograft containing multipotent adult progenitor cells or recombinant human bone morphogenetic protein-2A repeated-measures ANOVA indicated that while patients significantly reduced their ODI score (p < 0.001), there was no difference in the change in ODI when compared between the patients that received either biologic (p = 0.966)Back to article page